Controlled study on enteropathogens in travellers returning from the tropics with and without diarrhoea  by Paschke, C. et al.
Controlled study on enteropathogens in travellers returning from the
tropics with and without diarrhoea
C. Paschke, N. Apelt, E. Fleischmann, P. Perona, C. Walentiny, T. Lo¨scher and K.-H. Herbinger
Department of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians University of Munich, Munich, Germany
Abstract
Diarrhoea is the most frequent health problem among travellers in the tropics. However, data on the spectrum and relevance of ente-
ropathogens in international travellers with and without diarrhoea are limited. Stool samples from 114 cases of diarrhoea in travellers
returning from the tropics were collected for microbiological examination and PCR for norovirus genogroups I and II, enteroaggregative
Escherichia coli (EAEC), and enterotoxigenic E. coli (ETEC) producing heat-labile toxin (LT) and heat-stable toxin (ST). Travel and labora-
tory data of cases were compared with those of 56 travellers without diarrhoea. Among cases, EAEC was found in 45% of stool sam-
ples, followed by LT-ETEC (20%), ST-ETEC (16%), Blastocystis hominis (15%), Campylobacter jejuni (12%), norovirus (11%), Giardia lamblia
(6%), Shigella spp. (6%), and Salmonella spp., Cryptosporidium spp., and Cyclospora cayetanensis (3% each). However, only for EAEC, ST-
ETEC, Blastocystis and Campylobacter was the prevalence signiﬁcantly higher among cases than among controls. Co-infections were com-
mon: 61% for cases and 13% for controls. The most common travel destination was Asia (54%), followed by Africa (35%) and Latin
America (9%). The highest relative risk for diarrhoea was calculated for travellers to West Africa, East Africa, and South Asia. In this
study, EAEC, LT-ETEC and ST-ETEC were detected most frequently in cases of travellers’ diarrhoea. Although enteric infections with
EAEC, ST-ETEC and Campylobacter often cause diarrhoea, the pathogenetic relevance remains unclear for most of the other entero-
pathogens, because of signiﬁcant prevalence rates also being seen in controls without diarrhoea and the high frequency of co-infections.
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Introduction
The most frequent health problem among travellers to sub-
tropical and tropical regions is diarrhoea. Travellers’ diar-
rhoea (TD) is deﬁned as a passage of three or more
unformed stools in 24 h plus at least one additional sign or
symptom of enteric infection [1–3]. Depending on the type
of travel and travel destination, TD occurs in a range
between 10% and 60% of international travellers during their
journey, mainly in tropical countries and thereafter [2–6].
TD can result in both acute (duration £14 days) and per-
sistent (duration >14 days) illness. Although most episodes
are self-limiting and usually last for less than a week, persis-
tent diarrhoea develops in approximately 3% of travellers vis-
iting high-risk regions [7].
The aetiological agents causing acute TD include bacterial,
viral and parasitic enteropathogens. The most common bac-
terial agents causing acute TD worldwide are enteroaggrega-
tive Escherichia coli (EAEC) and enterotoxigenic E. coli (ETEC)
producing heat-labile toxin (LT), heat-stable toxin (ST), or
both [3,8]. Noroviruses are considered to constitute the
most important non-bacterial cause of acute TD [9]. How-
ever, data are available only for speciﬁc destinations or lim-
ited outbreaks [9,10].
From identiﬁcation of the aetiology of persistent TD, it
has been suggested that, besides protozoal parasites, EAEC
may play a role, although the pathogenesis is not completely
known [3,7,11–14]. However, EAEC and other bacterial
enteropathogens have also been found in asymptomatic trav-
ellers during and after travel [7].
The present study analysed the results of microbiological
stool investigations, including PCR for noroviruses, ETEC
and EAEC among travellers from Germany who presented
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with acute or persistent diarrhoea after returning from trop-
ical countries.
Materials and Methods
Study population
In this study, over a time period of more than 3 years
(August 2006 to November 2009), a representative number
of patients presenting with TD and control patients were
included. All participants presented at the Department of
Infectious Diseases and Tropical Medicine (DITM) of the
Ludwig-Maximilians University of Munich, Germany, within
15 days after their return.
Deﬁnition of cases and controls
Cases were deﬁned as patients with TD who reported three
or more unformed stools in 24 h with at least one accompa-
nying symptom of enteric infection (i.e. nausea, vomiting,
urgency, loss of appetite, or abdominal pain). Controls were
deﬁned as patients with any kind of symptom except symp-
toms of enteric infection. The controls were chosen ran-
domly, from those visiting the DITM in the same period of
time as cases.
Stool collection
From a total number of 170 patients, stool samples were
collected on the day of presentation at the DITM. Stool sam-
ples were prepared as 20% solutions in 1 mL of DNA-free
water, and immediately stored at )80C until extraction.
The stool samples were also processed in the course of rou-
tine stool diagnostics, in order to examine every stool sam-
ple for enteric bacteria and parasites.
Extraction of nucleic acid
After centrifugation of the diluted faecal samples for 10 min
at 3500 g, RNA was extracted from 140 lL of the super-
natant with a QIAamp viral RNA mini kit (Qiagen, Hilden,
Germany), according to the manufacturer’s instructions
[15–17]. Extracted RNA was stored at )80C until testing.
DNA was extracted with the QIAamp DNA stool mini kit
(Qiagen), by following the manufacturer’s manual [18,19].
Extracted DNA was kept at )20C until testing.
Norovirus PCR of stool specimens
For detection of norovirus genogroup I (GI) and geno-
group II (GII), the stool samples were tested by the reverse
transcription loop-mediated isothermal ampliﬁcation method
described by Fukuda et al. [17,20,21]. All steps from cDNA
synthesis to ampliﬁcation and visual ﬂuorescence detection
were performed in one reaction tube in a LightCycler
(Roche Diagnostics, Mannheim, Germany). With the
reagents of a norovirus GI/GII Detection kit (Eicken, Tokyo,
Japan), the reverse transcription loop-mediated isothermal
ampliﬁcation assay was performed in a reaction mixture of
10 lL containing 5.0 lL of 2· reaction mix, 0.4 lL of
enzyme mix, 1.0 lL of primer mix, 0.4 lL of ﬂuorescent
detection reagent, and 2.0 lL of RNA extract. The reaction
mixture was subsequently incubated at 63C for 60 min for
ampliﬁcation, and heated at 80C for 5 min for enzyme inac-
tivation.
Escherichia PCR of stool specimens
The PCRs for ETEC and EAEC were performed with two
primers for each target gene in separate reaction proce-
dures. The target genes for the E. coli strains, the primer
sequences and respective concentrations were selected as
published elsewhere [12,19,22].
The 50-lL reaction mixture of the PCR for EAEC con-
tained 5.0 lL of 10· PCR Gold Buffer and 2.5 mM MgCl2,
whereas the optimized PCR protocol for ETEC was con-
ducted in a 20-lL reaction mixture containing 2.0 lL of 10·
PCR Gold Buffer and 4 mM MgCl2. In addition, both PCR
assays included 0.2 mM each dNTP, 0.025 U/lL of AmpliTaq-
Gold DNA polymerase (Applied Biosystems, Foster City,
CA, USA), 2.0 lL of the stool DNA template, and the PCR
primers.
Thermocycling conditions have been published elsewhere
[19,22]. After electrophoresis, the ampliﬁed products
(10 lL) were visualized on ethidium bromide-stained 2% aga-
rose gels.
Estimated relative risk (RR) for travellers
The RR of infections with one of these ﬁve potential causa-
tive pathogens for diarrhoea among travellers from Germany
was estimated as follows: division of the number of positive
cases for one of these pathogens (in the numerator) by the
number of air passengers from Germany ﬂying in a certain
region (in the denominator). The calculated proportion of
travellers from Germany to Central America served as a ref-
erence proportion, with an RR of 1.00 (Table 4).
Statistical analysis
Approximative tests (chi-squared tests) and t-tests as para-
metric tests were conducted with Stata software, version 9.0
(Stata Corporation, College Station, TX, USA) and EpiInfo,
version 3.3.2 (Centers for Disease Control and Prevention,
CDC, Atlanta, GA, USA). Signiﬁcant differences were deﬁned
as p-values below 0.05 or as no overlapping of 95% CIs of
proportions.
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Ethical clearance and informed patient consent
Ethical clearance for the study was sought through the Ethi-
cal Committee of the Medical Faculty at the University of
Munich, Germany. Clinical and laboratory data were used
only from patients who had given written informed consent
to participate in this study, or after written informed consent
had been obtained from the legal care-takers in the case of
minors.
Results
Study population
During the study period, faecal samples from 170 patients
were collected at the DITM after their travel to subtropical
and tropical countries: 114 (67.1%) patients were deﬁned as
cases, and 56 (32.9%) patients as controls. There were more
females among the cases (56.1%) than among the controls
(44.6%). The difference was not signiﬁcant (p 0.16). For
cases, the age range was 2–80 years, and the mean age
37.7 years. Most cases (73.7%) were aged 20–49 years. The
age distribution of controls was not signiﬁcantly different
(Table 1).
Travel data
The travel destination of the cases and controls was
mainly Asia (50.9% and 55.4%, respectively), followed
by Africa (38.6% and 26.8%, respectively), Latin America
(7.0% and 17.9%, respectively), and Europe (2.6% and
0%, respectively). One case (0.9%) travelled around the
world. Among the controls, only the number of travellers
to Latin America was signiﬁcantly (p 0.03) higher.
The majority of the cases (62.3%) and the controls
(53.6%) travelled for a duration of 8–30 days. Most cases
and controls travelled for business (38.6% and 32.1%,
respectively) or adventure (23.7% and 19.6%, respectively).
According to the duration and type of travel, no signiﬁcant
difference between cases and controls were found
(Table 1).
Clinical data on cases with TD
In 109 (95.6%) of the 114 cases, the duration of diarrhoea
(from onset of diarrhoea up to time of stool collection) was
known. Of these, 31 (28.4%) reported suffering from diar-
rhoea for 0–3 days, 53 (48.6%) for 4–14 days, and 25
(22.9%) for more than 14 days (up to 180 days). Besides
diarrhoea, 46 (40.4%) cases had nausea, 25 (21.9%) suffered
from abdominal pain and ﬂatulence (21.9% each), and 14
(12.3%) suffered from vomiting.
Laboratory results for noroviruses and Escherichia spp.
Among the cases, 10.5% were positive for norovirus (2.6%
for GI and 8.8% for GII), including one case who was
co-infected with both genogroups. Furthermore, 45.0% were
positive for EAEC, 20.0% for LT-ETEC, and 16.2% for
ST-ETEC, whereas 11 cases were co-infected with EAEC and
LT-ETEC or with EAEC and ST-ETEC, and four cases were
co-infected with EAEC, LT-ETEC, and ST-ETEC. Additionally,
seven cases were co-infected with LT-ETEC and ST-ETEC.
Nine co-infections with noroviruses and Escherichia spp. were
also found. Signiﬁcantly different prevalence rates between
TABLE 1. Baseline data of 170 patients (114 cases and 56
controls) who presented for the ﬁrst time at the Depart-
ment of Infectious Diseases and Tropical Medicine (DITM)
of the University of Munich, Germany, <15 days after
returning from travel abroad
Variables Casesa (%) Controlsb (%) p-value
Cases and controls 114 56
Case/control ratio 2.04 1.00
Sex
Male 50 (43.9) 31 (55.4) 0.16
Female 64 (56.1) 25 (44.6) 0.16
Age (years)
Range 2–80 1–66
Mean 37.7 35.1
Median 35 34
Age group (years)
0–9 5 (4.4) 2 (3.6) 0.80
10–19 2 (1.8) 0 0.32
20–29 30 (26.3) 19 (33.9) 0.30
30–39 33 (28.9) 16 (28.6) 0.96
40–49 21 (18.4) 11 (19.6) 0.85
50–59 7 (6.1) 4 (7.1) 0.80
60–69 12 (10.5) 4 (7.1) 0.48
70–80 4 (3.5) 0 0.16
Travel destination
Asia 58 (50.9) 31 (55.4) 0.58
Africa 44 (38.6) 15 (26.8) 0.13
Latin America 8 (7.0) 10 (17.9) 0.03*
Europe 3 (2.6) 0 0.22
Around the world 1 (0.9) 0 0.48
Duration of travel (days)
1–7 15 (13.2) 5 (8.9) 0.42
8–30 71 (62.3) 30 (53.6) 0.28
31–90 17 (14.9) 12 (21.4) 0.29
>90 11 (9.6) 9 (16.1) 0.22
Type of travel
Business travel 44 (38.6) 18 (32.1) 0.41
Adventure travel 27 (23.7) 11 (19.6) 0.55
All-inclusive tour 19 (16.7) 11 (19.6) 0.63
VFR 15 (13.2) 7 (12.5) 0.90
DAW, missionary 6 (5.3) 2 (3.6) 0.63
Students’ exchange 2 (1.8) 3 (5.4) 0.19
Immigration 1 (0.9) 1 (1.8) 0.61
Other or unknown 0 3 (5.4) 0.01*
VFR, visiting friends and relatives; DAW, development aid workers.
aIn this study, cases were deﬁned as patients with travellers’ diarrhoea who
reported three or more unformed stools in 24 h with at least one accompany-
ing sign or symptom of enteric infection (i.e. nausea, vomiting, urgency, loss of
appetite, or abdominal pain).
bIn this study, controls were deﬁned as patients with any kind of symp-
toms—except for gastrointestinal symptoms typical of enteric infection (i.e. nau-
sea, vomiting, urgency, loss of appetite, or abdominal pain)—in the last 14 days
before presentation at the DITM. The controls were chosen randomly, from
those visiting DITM at the same time as cases.
*Signiﬁcant p-values: deﬁned as p <0.05.
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cases and controls were found only for EAEC (p <0.01) and
ST-ETEC (p 0.02) (Table 2).
In 109 cases with data available on TD duration, there
were no signiﬁcant differences in the percentages of noro-
virus, EAEC, LT-ETEC and ST-ETEC among cases of acute
and persistent (duration >14 days) diarrhoea (Table 3).
Laboratory results of other pathogens
The prevalence of other potential causative pathogens for
diarrhoea among the cases was as follows: Blastocystis hominis
14.9%, Campylobacter jejuni 12.3% Giardia lamblia 6.1%, Shigella
spp., 6.1%, Salmonella spp., and Cryptosporidium spp. and
Cyclospora cayetanensis 2.6% each. Signiﬁcantly different preva-
lence rates between cases and controls were found only for
B. hominis (p 0.03) and C. jejuni (p <0.01) (Table 2).
Co-infections
Among the cases, in 4.4% (5/114) no infections were
detected, in 35.1% (40/114) infection with one pathogen was
detected, and in 60.5% (69/114) co-infections with two to
ﬁve potential causative pathogens for TD were detected; in
34.2% (39/114) two pathogens were found in the stool sam-
ple, in 19.3% (22/114) three pathogens were found, in 6.1%
(7/114) four pathogens were found, and in 0.9% (1/114) ﬁve
pathogens were found. Among the 69 cases with co-infec-
tions, in 20 (29.0%) protozoa and in 11 (15.9%) bacteria
other than Escherichia spp. were found to be potential causa-
tive pathogens.
Among the controls, in 55.4% (31/56) no infections were
detected, in 32.1% (18/56) infection with one pathogen was
detected, and in 12.5% (7/56) co-infections with two or
three potential causative pathogens for TD were detected; in
8.9% (5/56) two pathogens were found in the stool sample,
and in 3.6% (2/56) three pathogens were found. Among the
seven controls with co-infections, in two (28.6%) protozoa
and in three (42.9%) bacteria other than Escherichia spp.
were found to be potential causative pathogens.
Estimated RR for travellers
The highest RRs for enteric infections with noroviruses or
Escherichia spp. among travellers from Germany were found
after return from West Africa (RR 4.14), East Africa
(RR 3.27), South Asia (RR 2.58), and Central America
(RR 1.00; reference). Considering the number of air travel-
lers, Africa was the continent with the highest risk for
enteric infections with noroviruses or Escherichia spp.
(RR 0.80) (Table 4).
Discussion
In our controlled study, data on travel and on diagnostics for
stool samples from cases with TD were analysed. We
focused on norovirus GI and GII, EAEC, and ETEC producing
LT and ST, which we diagnosed by speciﬁc PCR.
In the present study, EAEC was the most common
enteropathogen detected in 45% of our cases and, in com-
parison with controls; it was signiﬁcantly associated with
diarrhoea. This implicates EAEC as an important aetiological
cause of TD. ETEC was identiﬁed in more than 29% of our
cases, and was second to EAEC, which has usually been
TABLE 2. Comparison of laboratory results between cases
with travellers’ diarrhoea and controls
Variables Casesa (%) Controlsb (%) p-value
Escherichia coli: EAEC c
Positive 50 (45.0) 9 (16.4) <0.01*
Negative 61 (55.0) 46 (83.6)
E. coli: LT c
Positive 22 (20.0) 12 (21.8) 0.79
Negative 88 (80.0) 43 (78.2)
E. coli: ST c
Positive 18 (16.2) 2 (3.6) 0.02*
Negative 93 (83.8) 53 (96.4)
Blastocystis hominis
Positive 17 (14.9) 2 (3.6) 0.03*
Negative 97 (85.1) 54 (96.4)
Campylobacter jejuni
Positive 14 (12.3) 0 <0.01*
Negative 100 (87.7) 56 (100)
Norovirus (genogroups I and II)
Positive 12 (10.5) 2 (3.6) 0.12
Negative 102 (89.5) 54 (96.4)
Giardia lamblia
Positive 7 (6.1) 3 (5.4) 0.84
Negative 107 (93.9) 53 (94.6)
Shigella spp.
Positive 7 (6.1) 0 0.06
Negative 107 (93.9) 56 (100)
Salmonella spp.
Positive 3 (2.6) 3 (5.4) 0.37
Negative 111 (97.4) 53 (94.6)
Cryptosporidium spp.
Positive 3 (2.6) 0 0.22
Negative 111 (97.4) 56 (100)
Cyclospora cayetanensis
Positive 3 (2.6) 0 0.22
Negative 111 (97.4) 56 (100)
EAEC, enteroaggregative E. coli; LT, heat-labile toxin; ST, heat-stable toxin.
The stool specimens of all 114 cases and 56 controls were tested for norovirus
genogroup I, norovirus genogroup II, EAEC, enterotoxigenic E. coli producing LT
and ST, and other potential causative pathogens for diarrhoea. Only pathogens
with at least three positive samples each among the cases are shown here.
Among the cases, one stool sample each was positive for Isospora belli, Dient-
amoeba fragilis, and Schistosoma mansoni. Among the controls, one stool sample
each was positive for Schistosoma mansoni and Trichuris trichiura.
aIn this study, cases were deﬁned as patients with travellers’ diarrhoea who
reported three or more unformed stools in 24 h with at least one accompany-
ing sign or symptom of enteric infection (i.e. nausea, vomiting, urgency, loss of
appetite, or abdominal pain).
bIn this study, controls were deﬁned as patients with any kind of symp-
toms—except for gastrointestinal symptoms typical of enteric infection (i.e. nau-
sea, vomiting, urgency, loss of appetite, or abdominal pain)—in the last 14 days
before presentation at the Department of Infectious Diseases and Tropical Med-
icine (DITM). The controls were chosen randomly, from those visiting the DITM
at the same time as cases.
cClear PCR results were not available from three cases and one control for the
diagnosis of EAEC, from four cases and one control for the diagnosis of LT, and
from three cases and one control for the diagnosis of ST.
*Signiﬁcant p-values: deﬁned as p <0.05.
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described as the second most frequent enteropathogen in
worldwide studies [3,8,13]. Although both LT-ETEC and ST-
ETEC are known to be causative enteropathogens for TD,
we found a signiﬁcant association with TD only for ST-
ETEC. Among travellers returning from Africa and Asia,
EAEC was more often found in stool samples than ETEC,
TABLE 3. Duration of diarrhoea of 114 casesa with traveller’s diarrhoea: distribution of the number of cases with acute (dura-
tion of diarrhoeab <15 days) and persistent (duration of diarrhoeab >14 days) diarrhoea compared with positive laboratory
results for norovirus (genogroups I and II), enteroaggregative Escherichia coli (EAEC), and enterotoxigenic E. coli (ETEC) pro-
ducing heat-labile toxin (LT), heat-stable toxin (ST), or both
Variables
Norovirus
(%) EAEC (%) LT-ETEC (%) ST-ETEC (%)
No. of
infections (%) Casesc (%)
0–14 daysd 9 (75.0) 36 (75.0) 15 (71.4) 15 (88.2) 75 (76.5) 84 (77.1)
15–180 daysd 3 (25.0) 12 (25.0) 6 (28.6) 2 (11.8) 23 (23.5) 25 (22.9)
0–180 days 12 (100) 48 (100) 21 (100) 17 (100) 98 (100) 109 (100)
p-value 0.89 0.73 0.54 0.21
0–180 days 12 48 21 17 98 109 (95.6)
Duration not known 0 2 1 1 4 5 (4.4)
Total 12 50 22 18 102 114 (100)
aIn this study, cases were deﬁned as patients with travellers’ diarrhoea who reported three or more unformed stools in 24 h with at least one accompanying sign or symp-
tom of enteric infection (i.e. nausea, vomiting, urgency, loss of appetite, or abdominal pain).
bDuration of diarrhoea: time difference between beginning of symptom and ﬁrst presentation at the Department of Infectious Diseases and Tropical Medicine (DITM).
cIn this study, controls were deﬁned as patients with any kind of symptoms—except for gastrointestinal symptoms typical of enteric infection (i.e. nausea, vomiting, urgency,
loss of appetite, or abdominal pain)—in the last 14 days before presentation at the DITM. The controls were chosen randomly, from those visiting the DITM at the same
time as cases.
dDiarrhoea of 14 days or less is deﬁned as acute, whereas longer-lasting diarrhoea of >14 days is deﬁned as persistent. The end of diarrhoea is not known.
TABLE 4. Travel destinations of 114 travellers from Germany returning with diarrhoea, stratiﬁed into ﬁve subgroups with
positive PCR results for enteroaggregative Escherichia coli (EAEC), for enterotoxigenic E. coli (ETEC) producing heat-labile
toxin (LT) or heat-stable toxin (ST), and for norovirus genogroups I and II
Region of destination
Part of region
Casesa
No. of intestinal
infections
No. of air
passengers (·106)b RRcNorovirus (%) EAEC (%) LT-ETEC (%) ST-ETEC (%)
Asiad
South Asia 7 (58.3) 18 (36.0) 7 (31.8) 5 (27.8) 37 (36.3) 1.133 2.58
Southeast Asia 0 5 (10.0) 2 (9.1) 1 (5.6) 8 (7.8) 1.478 0.43
East Asia 1 (8.3) 1 (2.0) 1 (4.5) 1 (5.6) 4 (3.9) 2.458 0.13
Central Asia 0 1 (2.0) 0 0 1 (1.0) 0.192 0.41
Middle East 0 2 (4.0) 3 (13.6) 0 5 (4.9) 1.855 0.21
Total 8 (66.7) 27 (54.0) 13 (59.1) 7 (38.9) 55 (53.9) 7.116 0.62
Africa
West Africa 0 6 (12.0) 2 (9.1) 2 (11.1) 10 (9.8) 0.191 4.14
East Africa 3 (25.0) 4 (8.0) 1 (4.5) 4 (22.2) 12 (11.8) 0.290 3.27
North Africa 0 8 (16.0) 0 3 (16.7) 11 (10.8) 2.423 0.36
Central Africa 0 0 0 0 0 0.018 0
Southern Africa 0 2 (4.0) 1 (4.5) 0 3 (2.9) 0.634 0.37
Total 3 (25.0) 20 (40.0) 4 (18.2) 9 (50.0) 36 (35.3) 3.556 0.80
Latin America
Central America 0 1 (2.0) 2 (9.1) 1 (5.6) 4 (3.9) 0.316 1.00c
Caribbean 0 0 0 0 0 0.496 0
South America 0 2 (4.0) 2 (9.1) 1 (5.6) 5 (4.9) 0.790 0.50
Total 0 3 (6.0) 4 (18.2) 2 (11.1) 9 (8.8) 1.602 0.44
North America 0 0 0 0 0 6.954 0
Australia, Paciﬁc Region 0 0 0 0 0 0.309 0
Russia 0 0 0 0 0 0.132 0
Travel outside Europe 11 (91.7) 50 (100) 21 (95.5) 18 (100) 100 (98.0) 19.669 0.65
Europee 1 (8.3) 0 1 (4.5) 0 2 (2.0) NAe NAe
All 12 (100) 50 (100) 22 (100) 18 (100) 102 (100) NAe NAe
NA, not applicable; RR, relative risk.
aIn this study, cases were deﬁned as patients with travellers’ diarrhoea who reported three or more unformed stools in 24 h with at least one accompanying sign or symp-
tom of enteric infection (i.e. nausea, vomiting, urgency, loss of appetite, or abdominal pain).
bOfﬁcial total number of air passengers from Germany travelling to tropical and subtropical regions in Asia, Africa and Latin America in 2008: 12 274 352 (Statistisches
Bundesamt, Federal Bureau of Statistics, Wiesbaden, Germany).
cThe risk of acquiring an intestinal infection with norovirus genogroup I and genogroup II, or EAEC, or ETEC producing LT or ST among travellers from Germany travelling
to Central America was the reference value of 1.00. The RR for travellers travelling to other destinations was calculated by comparison with this reference value.
dAsia without Russia.
eEurope without Russia. No RR for travellers from Germany to other destinations in Europe was calculated, as most of them do not travel by aeroplane. RR was estimated
by number of air passengers only.
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whereas the prevalence was higher for ETEC among travel-
lers from Latin America. These ﬁndings have been published
previously [3,6].
As described previously, the present study demonstrates a
relatively low prevalence of noroviruses as a cause of TD,
with a rate of about 11% within our cases [9]. Among the
cases, norovirus GII was more prevalent than GI, which coin-
cides with reports of norovirus GII being the predominant
strain in outbreaks worldwide [9,10].
Co-infections with two or more enteropathogens were
common. In more than half of the cases, co-infections with
protozoa or bacteria were detected. We detected—like a
previous study published by Keskimaki et al.—signiﬁcantly
more co-infections per sample among cases than among con-
trols. Without identifying a particular enteropathogen as the
true cause of illness, the high rate of co-infections among
cases accentuates the existence of multiple pathogens as an
essential condition for triggering a symptomatic enteric infec-
tion [23]. However, among the co-infections in our cases,
the most frequent organisms found were B. hominis and C. je-
juni. Both showed a signiﬁcantly higher prevalence among
cases than among controls, indicating them as deﬁnite causes
of TD. Whereas C. jejuni has been well described as a major
bacterial enteropathogen for TD, especially in Asia, it still
remains unclear whether B. hominis is a human pathogen
associated with diarrhoea [3,24,25]. Nevertheless, our study
illustrates the new ﬁnding that B. hominis may complement
other enteric pathogens by causing TD.
The highest RR for diarrhoea caused by noroviruses,
EAEC or ETEC among travellers was calculated for the fol-
lowing destinations: West Africa, East Africa, and South Asia.
This observation conﬁrms these regions as high-risk areas
for TD [3].
The present study showed a high level of occurrence of
EAEC and LT-ETEC among the controls, at 16% and 22%,
respectively. In developing countries, the non-symptomatic
carriage of EAEC and other pathogroups of E. coli has
already been noted [23]. These high rates of carriage among
our controls may be explained by the high sensitivity of the
new PCR assays. Symptomatic infections with EAEC and
ETEC usually require high infectious doses, and also depend
on host immunity and variation in susceptibility [3,23]. In
particular, the high rate of non-symptomatic LT-ETEC infec-
tions may be related to a natural immunological effect, as
described previously [6].
The detection rates for EAEC, LT-ETEC, ST-ETEC and
norovirus were not signiﬁcantly different between cases of
acute and persistent diarrhoea. Therefore, these enteropath-
ogens may be associated with both acute and persistent diar-
rhoea. However, taking into regard the high prevalence rates
of these pathogens in controls, their aetiological role in cases
with persistent TD has to be assessed cautiously.
The study had some limitations. Rotavirus, which could be
another causative viral pathogen for TD, especially among
children, was not detected, as the great majority of our
study population was aged >20 years. The patients were not
followed up after presentation, for which reason no exact
data on the duration of diarrhoea were evaluated. Norovirus
genogroups III–V were not diagnosed, as GI and GII are
known to be the most frequent genogroups.
This study showed a moderate prevalence of norovirus,
B. hominis and C. jejuni among travellers with diarrhoea,
whereas the prevalence of EAEC and ETEC (LT-ETEC and
ST-ETEC) was high, especially when travellers returned from
West Africa, East Africa, and South Asia. Co-infections with
two or more enteropathogens are common, and a compre-
hensive diagnostic examination of stool samples is required
to identify the pathogens occurring in travellers. Whereas
enteric infections with EAEC, ST-ETEC and Campylobacter
often cause diarrhoea, the detection rates for other entero-
pathogens were not signiﬁcantly different between returning
travellers with and without diarrhoea.
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